<PAGE> 1
EXHIBIT (a)(14)
NEWS RELEASE
PO Box 105250, Atlanta, GA 30348
(770) 981-9460
www.harland.net
FOR MORE INFORMATION, CONTACT:
INVESTORS
Victoria P. Weyand, Vice President of Communications
770-593-5127
[email protected]
MEDIA
John Pensec, Director of Corporate Communications
770-593-5443
[email protected]
HARLAND EXTENDS TENDER OFFER FOR
CONCENTREX INCORPORATED TO AUGUST 22, 2000
ATLANTA (August 21, 2000) -- John H. Harland Company (NYSE: JH) today
announced that the pending cash tender offer by a wholly owned subsidiary of
Harland for all outstanding shares of common stock of Concentrex Incorporated
(Nasdaq: CCTX) has been extended.
The tender offer, which commenced on July 21, 2000, and was scheduled
to expire at 12:00 midnight, New York City time, on Friday, August 18, 2000, has
been extended to 12:00 midnight, New York City time, on Tuesday, August 22,
2000, unless further extended.
As previously announced, Harland received early termination of the
15-day waiting period for its acquisition of Concentrex Incorporated under the
Hart-Scott-Rodino Antitrust Improvements Act, on August 2, 2000.
As of 6:00 p.m. New York City time on August 18, 2000, 5,275,311
shares of Concentrex common stock had been tendered to Harland under the terms
of the tender offer and not withdrawn. Such tendered shares include
approximately 66,252 shares tendered pursuant to notices of guaranteed delivery.
The number of shares tendered and not withdrawn represents approximately 94.1%
of the outstanding shares of Concentrex.
---------------------
This announcement is neither an offer to purchase nor a solicitation of
an offer to sell shares of Concentrex. Harland has filed a tender offer
statement with the Securities and Exchange Commission (SEC) and Concentrex has
filed a solicitation/recommendation statement with respect to the offer.
Concentrex shareholders are advised to read the tender offer statement regarding
the acquisition of Concentrex referenced in this press release, and the related
solicitation/recommendation statement, including the amendments to these
documents which have been filed with the SEC. The tender offer statement
(including an offer to purchase, letter of transmittal and related tender
documents) and the solicitation/recommendation statement contain important
information which should be read carefully before any decision is made with
respect to the offer. These documents will be made available to all stockholders
of Concentrex at no expense to them. These documents will also be available at
no charge on the SEC's web site at www.sec.gov.
---------------------
ABOUT HARLAND
Atlanta-based John H. Harland Company (www.harland.net) is listed on
the New York Stock Exchange under the symbol "JH." Harland is a leading provider
of checks, financial software and direct marketing to the financial institution
market. Scantron Corporation (www.scantron.com), a wholly owned subsidiary, is a
leading provider of software services and systems for the collection, management
and interpretation of data to the financial, commercial and educational markets.
---------------------
ABOUT CONCENTREX
Concentrex, based in Portland, Oregon, is a leading provider of
technology-powered solutions to deliver financial services, including a broad
range of traditional software and services integrated with leading e-commerce
solutions that already enable its customers to serve more than 1 million home
banking customers. Concentrex serves over 5,500 financial institutions of all
types and sizes in the United States. Concentrex has major offices in 11
additional cities across the country. Its World Wide Web site is
www.concentrex.com.
---------------------
This press release contains statements which may constitute
"forward-looking
<PAGE> 2
statements." These statements include statements regarding the intent, belief or
current expectations of John H. Harland Company, Concentrex Incorporated and
members of their respective management, as well as the assumptions on which such
statements are based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance and involve
risks and uncertainties and that actual results may differ materially from those
contemplated by such forward-looking statements. Reference is made to the Risk
Factors and Cautionary Statements of Harland's Form 10-K and Form 10-Q and to
Concentrex's Securities and Exchange Commission reports filed under the
Securities Exchange Act.
